Furthermore, particular attention is paid to the pathogenic consequences of SMARCB1 loss including disturbances in cellular differentiation and lineage specification of neural crest cells underlying the tumorigenesis of either poorly differentiated pediatric rhabdoid tumours or more differentiated adult tumours such as schwannomas. This evidence concerns the gene SMARCB1 and neoplasm.